Overview

The Effects of Remimazolam on Cerebral Blood Flow Following General Anesthesia Induction

Status:
NOT_YET_RECRUITING
Trial end date:
2026-01-27
Target enrollment:
Participant gender:
Summary
This study will enroll 40 subjects aged 18 years or older scheduled for elective surgery under general anesthesia with endotracheal intubation. Basic medical history information will be collected. Subjects will be divided into two groups of 20 each: a remimazolam group and a propofol group. The study period will span from one day before surgery to one day after surgery. The study will assess middle cerebral artery cerebral blood flow following general anesthesia induction and postoperative anesthesia recovery.
Phase:
PHASE4
Details
Lead Sponsor:
Jun Zhang
Treatments:
Propofol
remimazolam